Source: Annual Congress 2011 - Small airways: important in COPD and severe asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. S. Postma (Groningen, The Netherlands). Clinical relevance and implication for therapy. Annual Congress 2011 - Small airways: important in COPD and severe asthma

Member's Comments

No comment yet.

Related content which might interest you: Recent advances from pathophysiology to medical therapy Source: Annual Congress 2010 - ERS Guidelines for the diagnosis and management of lymphangioleiomyomatosis Year: 2010 Concept and pre-clinical studies Source: Annual Congress 2010 - [italic]Ex vivo[/italic] graft evaluation and reconditionning in human lung transplantation Year: 2010 Therapeutic implications Source: Annual Congress 2011 - Why are small airways important in asthma? An ERS/World Allergy Organization joint symposium Year: 2011 How can we validate a predictive factor and bring it into clinical practice? Source: Annual Congress 2011 - Prognostic and predictive factors in lung cancer Year: 2011 Compliance with guidelines for pharmacological treatment of COPD: Real-life analyses Source: Annual Congress 2010 - What's new in pulmonary rehabilitation and chronic care in 2010 Year: 2010 Efficacy and safety of antibiotic treatment of stable COPD Source: Annual Congress 2010 - Treatment of bronchial infection: beyond the exacerbations Year: 2010 Clinical implications Source: Annual Congress 2007 - Pulmonary biomarkers in COPD Year: 2007 Current controversies in the treatment of COPD Source: Annual Congress 2011 - Lancet / ERS symposium - New frontiers in COPD Year: 2011 Applications of clinical exercise testing Source: Annual Congress 2010 - PG18 Postgraduate Course: Cardiopulmonary exercise testing in the evaluation of the respiratory patient Year: 2010 Evaluation and management of difficult asthma Source: Annual Congress 2010 - PG3 Core Curriculum Postgraduate Course: Asthma: from bench to bedside Year: 2010 Overview of treatment modalities Source: Annual Congress 2010 - PG19 Postgraduate Course: Treatment of obstructive sleep apnoea Year: 2010 Overview of treatment modalities Source: Annual Congress 2011 - PG15 Treatment of obstructive sleep apnoea Year: 2011 How pharmacokinetic/pharmacodynamic science informs dosage recommendations? Source: Annual Congress 2010 - PG17 GRACE Postgraduate Course: Antimicrobial treatment of LRTI: important new aspects for clinical practice Year: 2010 Clinical implications and novel therapies Source: International Congress 2018 – Accelerated ageing in lungs Year: 2018 Assessment and treatment of comorbidity: what efforts pay off? Source: Annual Congress 2011 - The non-parmacological management of COPD exacerbations Year: 2011 How to optimise the efficacy of pharmacological treatments? Source: Annual Congress 2011 - New advances in smoking cessation Year: 2011 The relationship between clinical prediction markers, radiological characteristics and 6 month outcome following acute pulmonary embolism Source: Annual Congress 2010 - Clinical management of venous thrombosis, pulmonary embolism and thrombophilia Year: 2010